We are live on ! Find out more
IFO

Intrepid Family Office Portfolio holdings

AUM $124M
1-Year Est. Return 37.91%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+37.91%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$122M
AUM Growth
+$51M
Cap. Flow
+$44.3M
Cap. Flow %
36.3%
Top 10 Hldgs %
67.98%
Holding
43
New
12
Increased
8
Reduced
10
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 5.72%
2 Energy 4.33%
3 Financials 3.98%
4 Healthcare 3.53%
5 Materials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSY icon
26
Invesco Ultra Short Duration ETF
GSY
$3.9B
$1M 0.82%
20,000
-15,000
-43% -$752K
NTRA icon
27
Natera
NTRA
$46.1B
$929K 0.76%
5,500
-3,000
-35% -$468K
NSLR
28
Neostellar Capital Corp
NSLR
$254M
$821K 0.67%
100,000
NVDA icon
29
NVIDIA
NVDA
$5.42T
$790K 0.65%
+5,000
New +$629K
RVT icon
30
Royce Value Trust
RVT
$2.3B
$753K 0.62%
+50,000
New +$717K
RFIX
31
Simplify Bond Bull ETF
RFIX
$45.1M
$713K 0.58%
15,000
PLTR icon
32
Palantir
PLTR
$413B
$682K 0.56%
+5,000
New +$586K
ORGO icon
33
Organogenesis Holdings
ORGO
$239M
$403K 0.33%
110,000
+10,000
+10% +$37.3K
EIS icon
34
iShares MSCI Israel ETF
EIS
$909M
$385K 0.32%
+4,058
New +$331K
HE icon
35
Hawaiian Electric Industries
HE
$2.14B
$324K 0.27%
30,497
+5,497
+22% +$57.3K
INDV icon
36
Indivior Pharmaceuticals
INDV
$4.58B
$221K 0.18%
15,000
-10,000
-40% -$116K
SJT
37
San Juan Basin Royalty Trust
SJT
$118M
$63.2K 0.05%
+10,574
New +$64.2K
CCCC icon
38
C4 Therapeutics
CCCC
$412M
$57.2K 0.05%
40,000
IOVA icon
39
Iovance Biotherapeutics
IOVA
$2.83B
$43K 0.04%
25,000
-15,000
-38% -$37.3K
FOCL
40
EDAP TMS S.A.
FOCL
$233M
$41K 0.03%
25,000
PFE icon
41
Pfizer
PFE
$153B
-65,000
Closed -$1.65M
TSLA icon
42
PUT
Tesla
TSLA
$1.3T
-15,000
Closed -$3.89M
WYNN icon
43
Wynn Resorts
WYNN
$10.6B
-7,500
Closed -$626K

Similar funds

Intrepid Family Office's Q2 2025 Portfolio in Review

As of Q2 2025, Intrepid Family Office held 43 positions worth $122M, up 72% from $71.1M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Intrepid Family Office deployed $44.3M of net new capital in Q2 2025, opening 12 new positions and adding to 8 existing holdings. Its largest new stake was SPDR Gold Trust: 60,000 shares worth $18.3M.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 7.8% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $7.03M trimmed.

  • Intrepid Family Office's largest Q2 2025 buy was SPDR Gold Trust: 60,000 shares worth $18.3M.
  • Intrepid Family Office added most to abrdn Physical Silver Shares ETF in Q2 2025, an estimated $1.6M increase.
  • Intrepid Family Office's biggest Q2 2025 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $7.03M.
  • Intrepid Family Office fully exited Pfizer in Q2 2025, selling an estimated $1.65M.
  • Intrepid Family Office's ten largest holdings make up 68% of its $122M portfolio in Q2 2025.
  • Intrepid Family Office opened 12 new positions and closed 3 in Q2 2025.
  • Intrepid Family Office's portfolio value rose 72% quarter-over-quarter to $122M.

Based on Intrepid Family Office's 13F filing for Q2 2025, filed 14 Aug 2025.